T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $883B
1-Year Return 25.8%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Quarter Return
+12.16%
1 Year Return
+25.8%
3 Year Return
+128.18%
5 Year Return
+198.37%
10 Year Return
+601.91%
AUM
$717B
AUM Growth
+$49.1B
Cap. Flow
-$16.2B
Cap. Flow %
-2.26%
Top 10 Hldgs %
31.78%
Holding
3,041
New
118
Increased
1,636
Reduced
968
Closed
151

Sector Composition

1 Technology 31.66%
2 Healthcare 16.93%
3 Consumer Discretionary 11.06%
4 Financials 10.59%
5 Communication Services 9.16%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
SOUN icon
2626
SoundHound AI
SOUN
$5.77B
$130K ﹤0.01%
+28,378
New +$130K
TIO
2627
DELISTED
Tingo Group, Inc. Common Stock
TIO
$130K ﹤0.01%
107,162
+24,862
+30% +$30.2K
SIGA icon
2628
SIGA Technologies
SIGA
$625M
$129K ﹤0.01%
25,395
+397
+2% +$2.02K
CDXS icon
2629
Codexis
CDXS
$224M
$128K ﹤0.01%
45,653
+1,395
+3% +$3.91K
RIGL icon
2630
Rigel Pharmaceuticals
RIGL
$669M
$128K ﹤0.01%
9,887
-1,395
-12% -$18.1K
GRTS
2631
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$127K ﹤0.01%
64,735
+17,835
+38% +$35K
BFX
2632
DELISTED
BowFlex Inc.
BFX
$127K ﹤0.01%
103,300
FGEN icon
2633
FibroGen
FGEN
$46.3M
$126K ﹤0.01%
1,852
-30,493
-94% -$2.07M
PRPH icon
2634
ProPhase Labs
PRPH
$19.9M
$126K ﹤0.01%
+17,300
New +$126K
PL icon
2635
Planet Labs
PL
$2.65B
$125K ﹤0.01%
38,690
+1,961
+5% +$6.34K
YMAB icon
2636
Y-mAbs Therapeutics
YMAB
$389M
$125K ﹤0.01%
18,282
-6,441
-26% -$44K
ATRA icon
2637
Atara Biotherapeutics
ATRA
$82.8M
$124K ﹤0.01%
3,065
+70
+2% +$2.83K
BEEM icon
2638
Beam Global
BEEM
$44M
$124K ﹤0.01%
11,900
DYN icon
2639
Dyne Therapeutics
DYN
$1.84B
$124K ﹤0.01%
10,943
-280,367
-96% -$3.18M
RES icon
2640
RPC Inc
RES
$1.02B
$124K ﹤0.01%
17,243
+3,297
+24% +$23.7K
CRIS icon
2641
Curis
CRIS
$22.2M
$123K ﹤0.01%
7,380
FPI
2642
Farmland Partners
FPI
$469M
$123K ﹤0.01%
+10,030
New +$123K
PTRA
2643
DELISTED
Proterra Inc. Common Stock
PTRA
$123K ﹤0.01%
102,308
-9,100
-8% -$10.9K
KPTI icon
2644
Karyopharm Therapeutics
KPTI
$54.6M
$122K ﹤0.01%
4,541
+510
+13% +$13.7K
NGS icon
2645
Natural Gas Services Group
NGS
$331M
$122K ﹤0.01%
12,288
SUP
2646
DELISTED
Superior Industries International
SUP
$122K ﹤0.01%
33,700
NGM
2647
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$122K ﹤0.01%
46,963
LCTX icon
2648
Lineage Cell Therapeutics
LCTX
$283M
$121K ﹤0.01%
85,336
-3,764
-4% -$5.34K
BTE icon
2649
Baytex Energy
BTE
$1.83B
$120K ﹤0.01%
+36,701
New +$120K
EVC icon
2650
Entravision Communication
EVC
$217M
$120K ﹤0.01%
27,109
+16,343
+152% +$72.3K